IXIARO (Japanese encephalitis vaccine/PF)
JAPANESE ENCEPHALITIS VACCINE · JAPANESE ENCEPHALITIS VACCINATION
VALNEVA
Drug class
Japanese Encephalitis Vaccine
The Japanese encephalitis vaccine represents an immunobiologic class of active immunizing agents formulated to prevent infection caused by the mosquito-borne Japanese encephalitis virus. Read more about Japanese Encephalitis Vaccine
2 drugs in this class 1 manufacturers
Drugs in Japanese Encephalitis Vaccine
IXIARO (PF) (Japanese encephalitis vaccine/PF)
JAPANESE ENCEPHALITIS VACCINE · JAPANESE ENCEPHALITIS VACCINATION
VALNEVA
Filter & compare in the drug finder →
Opens the drug finder with Japanese Encephalitis Vaccine preselected. Add indication or manufacturer filters there.
The Japanese encephalitis vaccine represents an immunobiologic class of active immunizing agents formulated to prevent infection caused by the mosquito-borne Japanese encephalitis virus.
Formulations primarily include inactivated cell-culture-derived or live-attenuated preparations that stimulate the host immune system to produce neutralizing antibodies against structural viral antigens, establishing humoral immunity and immunologic memory.
This vaccine class is indicated for pre-exposure prophylaxis in individuals at risk of exposure, including residents of and travelers to endemic areas across Asia and the Western Pacific, as well as laboratory personnel handling the virus.
Its therapeutic role is strictly preventive, aiming to avert severe neuroinvasive disease, encephalitis, permanent neurologic sequelae, and viral-induced mortality.
-
fda.gov
The Japanese encephalitis vaccine represents an immunobiologic class of active immunizing agents formulated to prevent infection caused by the mosquito-borne Japanese encephalitis virus
-
medlineplus.gov
The Japanese encephalitis vaccine represents an immunobiologic class of active immunizing agents formulated to prevent infection caused by the mosquito-borne Japanese encephalitis virus Formulations primarily include inactivated cell-culture-derived or live-attenuated preparations that stimulate the host immune system to produce neutralizing antibodies against structural viral antigens, establishing humoral immunity and immunologic memory This vaccine class is indicated for pre-exposure prophyla...
-
cdc.gov
This vaccine class is indicated for pre-exposure prophylaxis in individuals at risk of exposure, including residents of and travelers to endemic areas across Asia and the Western Pacific, as well as laboratory personnel handling the virus Its therapeutic role is strictly preventive, aiming to avert severe neuroinvasive disease, encephalitis, permanent neurologic sequelae, and viral-induced mortality
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.